Download predictors of survival for more than one year in

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Management of acute coronary syndrome wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Jatene procedure wikipedia , lookup

Cardiac arrest wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Electrocardiography wikipedia , lookup

Transcript
1180, either, cat: 58
PREDICTORS OF SURVIVAL FOR MORE THAN ONE YEAR IN PATIENTS
WITH PRIMARY CARDIAC AMYLOIDOSIS
H. Suradi, K. Hamidi Asl, M.K. Das, M. Benson
Indiana University, Indianapolis, IN, USA
Background: Cardiac involvement in primary amyloidosis (AL) is associated with poor
prognosis. We postulated that prognosis of primary cardiac amyloidosis (CA) is better
than reported.
Method: Clinical, ECG, echo and mortality data of 172 pts with histologically proven
primary amyloidosis were studied.
Results: 121 pts (age: 60+13.7 yrs; male, 66%) had CA (57 pts had positive cardiac
biopsy or autopsy, and 64 pts had CA by clinical criteria [CHF with LVH or low voltage
ECG]). The median survival was 15.9+3.2 months and 55% pts survived >1 year. CHF
was present in 81(72%) pts. Low voltage ECG, Q wave, and LVH were present in 39.9%,
43%, and 13% respectively. Echo revealed LVH, mitral regurgitation (MR), left atrial
enlargement and speckled appearance in 85%, 13%, 14% and 14.5% pts, respectively.
Univariate predictors of survival for >1year were absence of CHF (class II-IV), MR and
pericardial effusion, as well as presence of interventricular septum <1.5 cm (all p <0.05).
Absence of CHF (p=0.028, RR 1.86[95% CI: 1.1-3.25]) was the only multivariate
predictor of survival. Multi organ involvement, low voltage ECG, speckled appearance,
LVEF and pulmonary hypertension were not predictors for survival. Median survival
with CHF was 8.9 +2.1months compared to 31+6.3 months without CHF (P<0.001).
Conclusion: (1)Contrary to previous reports, the median survival of pts with primary CA
is 15.6 months and 55% pts survive >12 months. (2)CHF is the only multivariate
predictor of mortality in these patients.